Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: $0
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 2 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 10 most recent Form 4 transactions.
| Nov 2 | BBTX | Bambusa Therapeutics, Inc. | CCONV◆ | 37,399 | — | — | — | Open the original filing on SEC.gov |
| Nov 2 | BBTX | Bambusa Therapeutics, Inc. | CCONV◆ | 1,753 | — | — | — | Open the original filing on SEC.gov |
| Nov 2 | BBTX | Bambusa Therapeutics, Inc. | CCONV◆ | 10,450 | — | — | — | Open the original filing on SEC.gov |
| Nov 2 | BBTX | Bambusa Therapeutics, Inc. | CCONV◆ | 4,155 | — | — | — | Open the original filing on SEC.gov |
| Nov 2 | BBTX | Bambusa Therapeutics, Inc. | CCONV | 147,238 | — | — | +2.0% | Open the original filing on SEC.gov |
| Nov 2 | BBTX | Bambusa Therapeutics, Inc. | CCONV | 16,358 | — | — | +2.0% | Open the original filing on SEC.gov |
| Oct 29 | BBTX | Bambusa Therapeutics, Inc. | AGRANT◆ | 758,204 | — | — | — | Open the original filing on SEC.gov |
| Oct 29 | BBTX | Bambusa Therapeutics, Inc. | AGRANT◆ | 379,102 | — | — | — | Open the original filing on SEC.gov |